Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 14,903	$ 47,085
Accounts receivable, net	14,882	4,473
Inventory, net	1,178	0
Prepaid expenses and other current assets	3,664	2,572
Total current assets	34,627	54,130
Restricted cash	583	583
Property and equipment, net	13,921	12,201
Intangible assets, net	27,963	75
Other assets	259	278
Right-of-use lease assets	1,794	1,693
Goodwill	4,123	0
Total assets	83,270	68,960
Current liabilities:
Accounts payable	4,074	2,170
Accrued expenses	27,626	4,988
Deferred revenue, current portion	2,586	2,586
Research and development service obligation liability, current portion	649	1,406
Contingent consideration liability, current portion	438	0
Operating lease liabilities, current portion	254	0
Total current liabilities	35,627	11,150
Deferred revenue, net of current portion	8,726	10,665
Operating lease liabilities, net of current portion	3,801	3,613
Research and development service obligation liability, net of current portion	48	142
Research and development funding arrangement liability	25,000	25,000
Contingent consideration liability, net of current portion	2,942	0
Other long-term liabilities	366	71
Total liabilities	76,510	50,641
Commitments and contingencies (Note 10)
Stockholders’ equity
Common stock $0.0001 par value; 200,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 24,463,178 and 18,816,842 shares issued as of September 30, 2022 and December 31, 2021, respectively; 24,462,228 and 18,815,892 shares outstanding as of September 30, 2022 and December 31, 2021, respectively	2	2
Additional paid-in capital	314,170	297,441
Treasury stock at cost, 950 shares as of September 30, 2022 and December 31, 2021	(155)	(155)
Accumulated deficit	(307,257)	(278,969)
Total stockholders’ equity	6,760	18,319
Total liabilities and stockholders’ equity	$ 83,270	$ 68,960